Slingshot members are tracking this event:
Celgene Announces Phase 2 Data from RADIANCE Trial of Ozanimod
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Feb 18, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 2 Data, Ozanimod, Multiple Sclerosis